IMI2-2020-23-02
IMI2-2020-23-02
1 project · €6,500,000 total EU contribution (project-level) · 20 participating organizations · 12 countries with participants
Total EU funding
Sum of EC max contribution fields for distinct projects in this topic.
€6,500,000
Countries active
Participant organizations by country (headquarters in CORDIS).
- Germany (3)
- Netherlands (3)
- UK (3)
- Spain (2)
- France (2)
- AT (1)
- BE (1)
- CH (1)
- DK (1)
- Italy (1)
- LT (1)
- RU (1)
Open calls
From the EU Funding & Tenders Portal, linked to this topic code when it matches the call identifier. Sync via yarn etl:funding.
No open or forthcoming calls linked to this topic in the database yet.
Top organizations
By number of distinct projects in this topic.
- ARES GENETICS GMBH1 projects · AT
- TECHNICAL UNIVERSITY OF DENMARK DTU1 projects · DK
- DH1 projects · UK
- UT1 projects · DE
- EUROPEAN VACCINE INITIATIVE1 projects · DE
- GSKBIO1 projects · BE
- IP1 projects · FR
- ISCIII1 projects · ES
- Janssen Vaccines (f.k.a. Crucell Holland B.V.)1 projects · NL
- HOSPITAL OF LITHUANIAN UNIVERSITY OF HEALTH SCIENCE KAUNO KLINIKOS1 projects · LT
- LIFE SCIENCE NETWORK1 projects · DE
- PFIZER1 projects · UK
Projects
Page 1 of 1
| Project | Programme | EU contribution | Total cost | |
|---|---|---|---|---|
Predicting the Impact of Monoclonal Antibodies & Vaccines on Antimicrobial Resistance PrIMAVeRa · 101034420 | H2020 | €6,500,000 | €22,156 | Details |